The latest biotech news

News and Trends 16 Sep 2024

Vironexis’ AAV vector approach: The next frontier in cancer immunology?

Delve into Vironexis’ launch with a pipeline of 10 cancer drug candidates built around its AAV vectors platform.

September 16, 2024 - 6 minutesmins - By Jules Adam

News and Trends 12 Sep 2024

Biotech R&D crunch: The impact of the Inflation Reduction Act and economic challenges

Delve into the consequences of the Inflation Reduction Act and the broader economic conditions on biotech R&D.

September 12, 2024 - 7 minutesmins - By Jules Adam

News and Trends 11 Sep 2024

Can Europe revive its biopharma innovation leadership?

Find out if the biotech runner-up, Europe, can step up to boost research and revive its innovation leadership.

September 11, 2024 - 9 minutesmins - By Jules Adam

News and Trends 10 Sep 2024

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

Recent deals have zoned in on drugs that target long non-coding RNAs and major moves are currently being made on the R&D front.

September 10, 2024 - 5 minutesmins - By Roohi Mariam Peter

Psychedelic therapy market: FDA rejects Lykos' MDMA treatment

News and Trends 6 Sep 2024

Psychedelic therapies under scrutiny: What’s next after Lykos’ MDMA rejection?

Delve into the psychedelic-assisted therapy market and investors’ sentiment after the FDA’s decision about Lykos’ therapy.

September 6, 2024 - 8 minutesmins - By Jules Adam

News and Trends 4 Sep 2024

2024: a year of breakthroughs for endometrial cancer?

New treatments have been approved by regulators for endometrial cancer, which are regarded as major therapeutic breakthroughs.

September 4, 2024 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 2 Sep 2024

Are we in an AI bubble? Biotech AI startups’ value plummet and leads to restructuration

Delve into the downturn AI is experiencing in biotech: Is the bubble bursting or is the market correcting the high expectations?

September 2, 2024 - 13 minutesmins - By Jules Adam

News and Trends 28 Aug 2024

GLP-1 shortage: Can biotech companies keep up with rising demand?

How is the biotech industry responding to the GLP-1 drug shortage? We asked experts in the field to answer this question.

August 28, 2024 - 6 minutesmins - By Roohi Mariam Peter

News and Trends 27 Aug 2024

Could microbiome drugs be the key to unlocking checkpoint inhibitors’ potential?

As Microbiotica announces phase 1 approval for two microbiome drugs we delve into their potential in oncology and beyond.

August 27, 2024 - 11 minutesmins - By Jules Adam

News and Trends 20 Aug 2024

Fighting mpox: promising vaccines to watch

As Bavarian Nordic ramps up production of the only marketed mpox vaccine, a few clinical trials are underway to combat the outbreak.

August 20, 2024 - 6 minutesmins - By Roohi Mariam Peter

News and Trends 14 Aug 2024

CAR-T drugs and parkinsonism: a cause for concern?

CAR-T therapies come with boxed warnings of serious neurotoxic side effects. Now, growing concerns over parkinsonism have led to a clinical trial halt.

August 14, 2024 - 3 minutesmins - By Roohi Mariam Peter

News and Trends 13 Aug 2024

Biologics vs. drugs: What does Ipsen’s lost case against the FDA mean for the industry?

Ipsen has lost a court case against U.S. regulators to have its blockbuster cancer medication Somatuline Depot regarded as a biologic instead of a drug.

August 13, 2024 - 4 minutesmins - By Roohi Mariam Peter

Resources

Categories

Swiss biotech going strong in 2024: 18 companies to put on your radar

The ABC of biotech startup funding

Approaches

Therapeutic areas

Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR

Special Olympics: How is biotechnology revolutionizing sports performance worldwide?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us